Oose, this is what Johnson & Johnson would do. Nephros doesn't have any money. So first, they can't pay for this type of study. Second, they don't have any money to continue operations while they do the study.
This is going to unravel a lot faster. I bet they already have a fire sale deal on the HDF. I'm actually not that bent about it, it will be nice to get away from Nephros.